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'Specialty Medical Home' Seeks to Provide Patient-Centered Care for Patients with 
Inflammatory Bowel Diseases 
May 4, 2016 – A specialty medical home—providing expert medical care coordinated with attention 
to social support and mental health—is a promising new approach to patient-centered, cost-
effective care for patients with Crohn's disease and ulcerative colitis, according to a special 
"Future Directions" paper in the May issue of Inflammatory Bowel Diseases, official journal of the 
Crohn's & Colitis Foundation of America (CCFA). The journal is published by Wolters Kluwer.  
The inflammatory bowel diseases specialty medical home (IBD SMH) is "a new model of care that places 
the patient at the center of the medical universe," write Dr. Miguel D. Regueiro and colleagues of 
University of Pittsburgh Medical Center and UPMC Health Plan. They share their institution's experience 
with developing a specialty medical home to provide comprehensive care for IBD. 
Specialty Medical Home Approach for Coordinated Care of IBD 
The "patient-centered medical home" has emerged as a new model to improve coordination of 
healthcare services while controlling costs. So far, most studies of this approach have focused on 
primary care settings, with mixed results in terms of patient outcomes and healthcare spending. 
But for patients with IBD, most care is provided by gastroenterologists and other specialists. "Clinicians 
who care for these patients recognize that this population requires specialized and personalized care," 
Dr. Regueiro and coauthors write. 
Created in collaboration between healthcare providers and payers, the IBD SMH focuses on providing 
"high-quality, comprehensive, cost-effective, patient-centered care" for Crohn's disease and ulcerative 
colitis. While this approach can potentially improve care for all patients, it focuses on the relatively 
small group who incur disproportionately high costs. Specialists at UPMC found that 14 percent of 
patients accounted for nearly half of spending for IBD care. 
The IBD SMH seeks to address the high rates of emotional difficulties, pain, and poor social support 
experienced by these "high utilizers." Dr. Regueiro and colleagues explain that pain, stress, coping 
problems, anxiety, depression, and fatigue can all affect the disease process in IBD—contributing to 
worsened inflammation and increased healthcare needs. 
In addition to optimizing medical and surgical care, the specialty medical home approach aims to 
enhance behavioral skills, improve social support, and reduce stress. Care is provided by a team 
including gastroenterologists and personal nurse coordinators, as well as surgeons, behavioral health 
and pain specialists, dietitians, and other professionals.  
Key aspects of the specialty medical home approach include an IBD Patient Checklist to ensure that all 
recommended preventive care steps are followed; individualized psychological care, addressing the 
"brain-gut" connection by which stress, anxiety, and depression can lead to worsening of IBD; optimal 
approaches to pain management, including evidence-based nondrug approaches; and nutritional 
support to address the special dietary needs of people with IBD. 
Dr. Regueiro and colleagues believe the SMH IBD can provide "patient-centered care that improves the 
value and quality of the medical experience while reducing cost." They hope their experience will be 
helpful to other medical centers interested in developing specialty medical homes, for IBD or other 
chronic diseases requiring specialist care. 
  
But the authors emphasize that many challenges remain in optimizing the care provided by the IBD SMH 
and demonstrating its benefits in terms of improved patient care and reduced costs. Dr. Regueiro and 
colleagues conclude, "The future of healthcare will rely on chronic care models that have yet to be 
realized, and the gastroenterologist will play a central role in the IBD management paradigm of 
tomorrow." 
Crohn's disease is a painful, medically incurable illness that may cause inflammation anywhere along 
the digestive system. Crohn's disease and ulcerative colitis, which involves only the large intestine 
(colon), are the two main types of inflammatory bowel diseases. Some 1.6 million American adults and 
children suffer from Crohn's disease or ulcerative colitis. 
Click here to read "The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-
centered Care." 
Article: "The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered 
Care" (doi: 10.1097/MIB.0000000000000819) 
Note to editors: For further information, contact Erin Stoeber, Vice President of Marketing & 
Communications for the CCFA: phone 347-899-5479 or e-mail estoeber@ccfa.org.  
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